Alyeska Investment is a fund manager in Chicago with $15.05 bn assets under management.
Company profile
Website
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
IRS number
261919051
SEC advisor number
801-71962
FINRA CRD number
155058
AUM ?
$15.05 bn
(as of 19 Apr 23)
Accounts
3
(as of 19 Apr 23)
Employees
50
(38 investment advisory or research)
Address
Alyeska Investment
77 WEST WACKER DRIVE
7TH FLOOR
CHICAGO
IL 60601
77 WEST WACKER DRIVE
7TH FLOOR
CHICAGO
IL 60601
Office hours
Monday - Friday, 8:00 AM TO 6:00 PM
Phone
312-899-7902
Ownership
Owner | Title | From | %Ownership |
---|---|---|---|
Parekh, Anand, Christopher | Chief Executive Officer | 02/2008 | < 5% |
Bragg, Jason, Aaron | Chief Financial Officer | 02/2008 | < 5% |
Alyeska Investments, LLC | Limited Partner | 02/2008 | 50-75% |
Alyeska Investment Holdings Corp. | General Partner | 02/2008 | < 5% |
Parekh, Anand, Christopher | Managing Member | 02/2008 | > 75% |
Alyeska Investments, LLC | Owner | 02/2008 | > 75% |
Parekh, Anand, Christopher | Indirect Owner | 02/2008 | > 75% |
Cunningham, Brent, Metrick | Chief Compliance Officer | 02/2018 | < 5% |
Chang, Kenneth, J | Portfolio Manager | 12/2021 | 5-10% |
Mitchell, Randy, Stephen | Portfolio Manager | 12/2021 | 5-10% |
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Alyeska Investment Group, L.P. | $15.05 bn | |
Alyeska Master Fund, L.P. | $15.05 bn | Hedge Fund |
Aleutian Fund, LTD. | ||
Alyeska Fund, L.P. |
Latest filings (excl ownership)
No filings
Latest ownership filings
13F-HR
Quarterly holdings report by institutional manager
15 May 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
SC 13G
Tonix Pharmaceuticals Holding Corp.
14 Feb 24
SC 13G
Surrozen, Inc./DE
14 Feb 24
SC 13G
Nemaura Medical Inc.
14 Feb 24
SC 13G
bluebird bio, Inc.
14 Feb 24
SC 13G
Aligos Therapeutics, Inc.
14 Feb 24
SC 13G/A
Unity Biotechnology, Inc.
14 Feb 24
SC 13G/A
MedAvail Holdings, Inc.
14 Feb 24
SC 13G/A
Applied Therapeutics Inc.
14 Feb 24